• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Drug treatment in Switzerland: harm reduction, decentralization and community response.

作者信息

Klingemann H K

机构信息

Swiss Institute for the Prevention of Alcohol and Drug Problems, Lausanne, Switzerland.

出版信息

Addiction. 1996 May;91(5):723-36. doi: 10.1046/j.1360-0443.1996.9157238.x.

DOI:10.1046/j.1360-0443.1996.9157238.x
PMID:8935256
Abstract

This paper first outlines the history of illicit drug issues in Switzerland, and then describes drug treatment services and shifts in treatment concepts. In the last 15 years the drug treatment system in Switzerland has expanded considerably. In particular there has been an unprecedented growth of the non-residential sector and of low-threshold programmes, including methadone treatment, the establishment of injection rooms and controlled drug-prescription pilot projects. In the second part, the paper considers some selected factors that promote or impede changes in drug treatment systems, such as treatment policy and the public response to treatment measures. This is manifested in the influence of community action groups on local programme development.

摘要

相似文献

1
Drug treatment in Switzerland: harm reduction, decentralization and community response.
Addiction. 1996 May;91(5):723-36. doi: 10.1046/j.1360-0443.1996.9157238.x.
2
[New drug policies: the Geneva example].[新药政策:日内瓦的例子]
Psychiatr Enfant. 1994;37(2):577-99.
3
Drug and alcohol user treatment/intervention services in Russia--a Western perspective.俄罗斯的药物和酒精使用者治疗/干预服务——西方视角
Subst Use Misuse. 1996 Jan;31(1):103-14. doi: 10.3109/10826089609045801.
4
Shifting from an illegal-drug policy to a psychoactive substance policy.从非法药物政策转向精神活性物质政策。
Soz Praventivmed. 2006;51(3):128-9. doi: 10.1007/s00038-006-0028-x.
5
Treatment and services for drug users in Britain.英国为吸毒者提供的治疗与服务。
J Subst Abuse Treat. 1993 Nov-Dec;10(6):561-7. doi: 10.1016/0740-5472(93)90060-f.
6
How and why AIDS changed drug policy in Switzerland.艾滋病如何以及为何改变了瑞士的毒品政策。
J Public Health Policy. 2012 Aug;33(3):317-24. doi: 10.1057/jphp.2012.20.
7
The role of pharmacies in the care of drug users: what has changed in ten years. The case of a Swiss region.
Eur Addict Res. 2007;13(1):50-6. doi: 10.1159/000095815.
8
[Mangement of drug problems in Hungary].[匈牙利的药物问题管理]
Lege Artis Med. 2009 Sep;19(8-9):537-41.
9
Measuring substance abuse program treatment orientations: the Drug and Alcohol Program Treatment Inventory.衡量药物滥用项目的治疗取向:药物与酒精项目治疗量表
J Subst Abuse. 1995;7(1):61-78. doi: 10.1016/0899-3289(95)90306-2.
10
[Therapeutic strategies with drugs].[药物治疗策略]
Psychiatr Prax. 1994 Jan;21(1):1-2.

引用本文的文献

1
Challenges of methadone maintenance treatment decentralisation from Vietnamese primary care providers' perspectives.从越南基层医疗服务提供者的视角看美沙酮维持治疗去中心化面临的挑战。
Drug Alcohol Rev. 2023 May;42(4):803-814. doi: 10.1111/dar.13613. Epub 2023 Feb 27.
2
Successes and failures in treatment of substance abuse: Treatment system perspectives and lessons from the European continent.药物滥用治疗中的成功与失败:治疗体系视角及来自欧洲大陆的经验教训。
Nordisk Alkohol Nark. 2020 Aug;37(4):323-337. doi: 10.1177/1455072520941977. Epub 2020 Aug 17.
3
Fifteen years of heroin-assisted treatment in a Swiss prison-a retrospective cohort study.
瑞士监狱中十五年的海洛因维持治疗-一项回顾性队列研究。
Harm Reduct J. 2020 Oct 13;17(1):67. doi: 10.1186/s12954-020-00412-0.
4
The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids.瑞士监狱中阿片类激动剂治疗的可及性及其强制中断——辩护律师在处理使用阿片类药物的被拘留者时的态度、认知和经历
Front Psychiatry. 2020 May 14;11:395. doi: 10.3389/fpsyt.2020.00395. eCollection 2020.
5
High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment.高剂量苯二氮䓬类药物依赖:关于患者对起始用药、用药原因及获取途径认知的定性研究
PLoS One. 2015 Nov 10;10(11):e0142057. doi: 10.1371/journal.pone.0142057. eCollection 2015.
6
Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.阿片类药物维持治疗患者中HIV感染率的种族和性别差异——病例登记分析
Harm Reduct J. 2014 Aug 18;11:23. doi: 10.1186/1477-7517-11-23.
7
Open drug scenes: responses of five European cities.公开的吸毒场景:五个欧洲城市的应对措施
BMC Public Health. 2014 Aug 16;14:853. doi: 10.1186/1471-2458-14-853.
8
Mexico's drug policy reform: cutting edge success or crisis in the making?墨西哥的毒品政策改革:是前沿的成功还是正在形成的危机?
Int J Drug Policy. 2014 Sep;25(5):823-5. doi: 10.1016/j.drugpo.2014.05.014. Epub 2014 Jun 2.
9
Patterns, determinants and barriers of health and social service utilization among young urban crack users in Brazil.巴西城市年轻可卡因使用者的卫生和社会服务利用模式、决定因素和障碍。
BMC Health Serv Res. 2013 Dec 28;13:536. doi: 10.1186/1472-6963-13-536.
10
Policy progress for physician treatment of opiate addiction.医生治疗阿片类药物成瘾的政策进展。
J Gen Intern Med. 2002 May;17(5):361-8. doi: 10.1046/j.1525-1497.2002.10628.x.